Effect of intra-articular corticosteroid injection to total knee arthroplasty compere to non-injected patients in Paholpolpayuhasena hospital

Authors

  • Jaran Luangsa-ard Orthopedic, Phaholpolpayuhasena Hospital, Kanchanaburi Province.

Abstract

Knee osteoarthritis is a leading cause of chronic pain, disability, and decreased quality of life. Despite the long-standing use of intraarticular corticosteroids, there is an ongoing debate about their benefits and safety, especially perioperative and long-term post operative period, for example periprosthetic joint infection. The purpose of the study is to identify effect and complication associated with an intraarticular corticosteroid injection before total knee arthroplasty (TKA) from a single surgeon's database in patients underwent total knee arthroplasty in Paholpolpayuhasena hospital, Kanchanaburi province, Thailand.

Method We retrospectively reviewed a series of 129 patients who underwent primary TKA (Paholpolpayuhasena hospital, Kanchanaburi province, Thailand) from 1 January 2017 to 31 December 2019. In our study, the patients were divided into 2 groups: 68 patients who received an intraarticular injection before TKA and 61 patients who did not receive an injection before TKA. Demographics data, comorbidities, operative time, peri-operative blood loss and periprosthetic joint infection (PJI) were recorded. Complications and infection rate at a minimum of 12-months follow-up were compared between patients who received preoperative intraarticular corticosteroid injections and those who not received injection before TKA. The outcomes of both groups were compere using the t-test. A p value less than 0.05 are considered statistically significant.

Result  Of the 129 patients in the study, patients receiving an intraarticular injection before TKA (68 patients) did not have significant difference in operative time (66.04+5.67 min) compared to non-injection group (65.72+5.42 min), p=0.15 and no significant difference in peri-operative blood loss (586.32+93.50 vs 589.02+110.08 ml) between groups, p=0.26. No periprosthetic joint infection (PJI) found in both groups after 12 months follow up.

Conclusion Our findings support the safety of intraarticular corticosteroid injections for patients with symptomatic severe osteoarthritis of knee. No significant difference in operative time, peri-operative blood loss and no increased risk of infection among patients who received steroid injections prior to the surgery was identified from the present evidence. Treatment of severe osteoarthritis of knee with intraarticular steroid injections appears to be clinically and cost effective for the relief of symptoms of the disease. A multicenter prospective study with more defined variables is needed further investigate this issue.

References

L.A. Garcia Rodriguez, S. Hernandez-Diaz, The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents Arthritis Res, 3 (2001), pp. 98-101.

Jesevar DS, Brown GA, Jones DL, Matzkin EG, Manner PA, Mooar P, et al, American Acedemy of Orthopaedic Surgeons. The American Acedemy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee. 2nd ed. J Bone Surg AM. 2013;95:1885-6.

National Institutute for Health and Clinical Excellence. Osteoaerthritis: the care and management of osteoarthritis in adult. NICE [internet]. Available from: http:/nice.org.uk/CG177.

Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, Mcgowan J,et al. American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of non-pharmacologic and pharmacologic therapies in osteoarthritis of hand hip and knee. Arthritis Care Res. 2012;64:465-74.

แนวทางเวชปฏิบัติคณะกรรมการจัดทำแนวทางเวชปฏิบัติโรคข้อเข่าเสื่อม ราชวิทยาลัยแพทย์ออร์โธปิดิกส์แห่งประเทศไทย, คณะกรรมการจัดทำแนวทางเวชปฏิบัติโรคข้อเข่าเสื่อม สมาคมรูมาติสซั่มแห่งประเทศไทย, แนวทางเวชปฏิบัติโรคข้อเข่าเสื่อม. ราชวิทยาลัยแพทย์ ออร์โธปิดิกส์แห่งประเทศไทย; 2011.

A.V. Papavasilliou, D. L. Isaac, R. Marimuthu, A. Skyrme, A. Armitage. Infection in knee replacements after previous injection of intraarticular steroid. J Bone Joint Surg [Br] 2006; 88-B:321-3.

Bozic KJ, Kurtz SM, Lau E, Ong K, Chiu V, Vail TP, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468:45-51.

Vessely MB, Whaley AL, Harmsen WS, Schleck CD, Berry DJ. The Chitranjan Ranawat Award: Long-term survivorship and failure modes of 1000 cemented condylar total knee arthroplasties. Clin Orthop Relat Res. 2006;452:28-34.

Wilson MG, Kelley K, Thornhill TS. Infection as a complication of total knee-replacement arthroplasty. Risk factor and treatment in sixty-seven cases. J Bone Joint Surg AM. 1990;72:878-83.

Windsor RE, Bono JV. Infected total knee replacement. J Am Acad Orthop Surg. 1994;2:44-53.

Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the medicare population. Clin Orthop Relat Res. 2010;468:52-6.

Aravind Desai, Sreekumar Ramankutty, Tim Board, Videsh Raut. Does intraarticular steroid infiltration increase the rate of infection in subsequent total knee replacements? The Knee. 2009;262–264.

Parvizi J, Tan TL, Goswami K, Higuera C, Della Valle C, et al. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty. 2018;33(5):1309-14.

Downloads

Published

2022-04-22

How to Cite

1.
Luangsa-ard J. Effect of intra-articular corticosteroid injection to total knee arthroplasty compere to non-injected patients in Paholpolpayuhasena hospital. Phahol Hosp J [internet]. 2022 Apr. 22 [cited 2025 Jun. 1];10(28):5-14. available from: https://he04.tci-thaijo.org/index.php/PPHJ/article/view/1022

Issue

Section

Original Articles